Related Experiment Video

Updated: Aug 21, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

The case for blood pressure control in risk groups

L M Ruilope1, M Volpe

  • 1Hospital 12 de Octubre, Servico di Nefrologia, Madrid, Spain.

International Journal of Clinical Practice
|November 9, 2004
PubMed

Insights

Hypertension often coexists with other cardiovascular disease risk factors. Combination therapy, such as angiotensin receptor blockers with diuretics, is effective for managing blood pressure and overall risk in high-risk patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension frequently presents with comorbid cardiovascular disease (CVD) risk factors.
  • Individualized CVD risk assessment is crucial for effective patient management.
  • Elevated blood pressure and CVD risk factors are interconnected, necessitating comprehensive treatment strategies.

Purpose of the Study:

  • To emphasize the importance of tailored treatment approaches for hypertensive patients.
  • To highlight the benefits of combination therapy in reducing overall cardiovascular risk.
  • To discuss the role of the Valsartan long-term evaluation (VALUE) trial in understanding combination treatment.

Main Methods:

  • Review of existing literature on hypertension and cardiovascular disease.
  • Analysis of risk factor profiles in hypertensive individuals.
  • Consideration of data from major clinical trials, including the VALUE trial.

Main Results:

  • Hypertension management requires addressing multiple cardiovascular risk factors.
  • Combination therapy, particularly with angiotensin receptor blockers and diuretics, offers a safe and effective approach.
  • The VALUE trial provides critical insights into combination treatment for high-risk populations.

Conclusions:

  • Individualized risk assessment and tailored treatment are paramount in hypertension management.
  • Combination therapy is essential for effectively lowering both blood pressure and overall cardiovascular risk.
  • Further research and clinical trials like VALUE are vital for optimizing hypertension treatment strategies.

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...